Darcy Forman, Chief Delivery Officer at Science 37, talks about Science 37's trailblazing role in evolving how clinical research is conducted. Founded in 2014, Science 37's mission is to accelerate and enhance the quality of clinical research by expanding access to a new, more diverse patient population with their Metasite™ - a site without borders. This innovative, decentralized trial approach has redefined the clinical trial landscape, making it more inclusive and patient-centric by reducing barriers to participate in clinical studies.

Darcy shares how Science 37 leverages unified technology, standardized processes, and a patient-centric approach to accelerate clinical research. Using a diverse array of workflow orchestration, wearable tech, and other digital tools, Science 37 effectively transitions trial delivery from traditional research clinics into patient's homes, addressing a multitude of logistical issues while enabling more patients to benefit from experimental therapies.

Darcy further highlights the key role of Science 37's patient recruitment strategies, including a unique omnichannel approach. This approach taps into a global healthcare provider network, pharmacies, lab partners, digital media, and advocacy groups to identify potential trial participants. Darcy also underscores the importance of collaboration within the pharmaceutical and biotech industry to further propel innovation in the clinical trial space. In conclusion, Darcy shares her vision for a future where clinical trials are more accessible, efficient, and patient-centric, emphasizing the need for continuous improvement & collaboration to realize this vision.

Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation.

Please take a moment and let us know what you think of the podcast, access our feedback survey here.

#52, Accelerating Clinical Trials & Making Research More Accessible: Darcy Forman, Chief Delivery Officer of Science 37